Japan· JP-2129402A1040
ベラパミル塩酸塩
A verapamil product containing ベラパミル塩酸塩, registered in Japan by エーザイ, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Verapamil is registered in 17 of 19 countries.
Countries holding a registration under ATC C08DA01 (verapamil), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 10 of them publish a price we can compare per daily dose
Verapamil · ATC C08DA01
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of verapamil costs, country by country.
Normalised to the WHO defined daily dose (0.24 g), the median price runs from $0.21 in France to $0.95 in Switzerland — a ×4.6 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Verapamil · price per daily dose (0.24 g)
USD · FX 28 Sept 2026
- CH Switzerland$0.95
- IT Italy$0.31
- FR France$0.21
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ベラパミル塩酸塩
- Manufacturer
- エーザイ
- Country
- Japan (JP)
- ATC code
- C08DA01
- ATC class
- Verapamil
- Defined daily dose
- 0.24 g, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
467 interactions on record for verapamil.
Graded by severity as the source publishes them — 52 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Verapamil · interactions on record
467 records
- 52 severe
- 223 moderate
- 23 minor
- 143 info
Most severe, free to view
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- NaloxegolA06AH03severe
- LoperamideA07DA03severe
26 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C08DA01
Verapamil, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d901af98-7180-40bf-8a90-7c0d6556d921 GET /v1/drugs/d901af98-7180-40bf-8a90-7c0d6556d921?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "０．２５％２ｍＬ１管",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "2129402A1040",
"category": "注射薬",
"price_yen": 192,
"generic_name": "ベラパミル塩酸塩",
"product_name_jp": null,
"therapeutic_class": "2129",
"transitional_expiry": null
}See everything about verapamil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.